GenSight will attend the 1st event dedicated to gene therapy for ocular diseases “Future is now: Leaders in Ocular Gene Therapy Meeting“, to be held at the Nikko Hotel in San Francisco (CA) on Wednesday October 9, 2019 from 1:00pm to 5:00pm PDT.

Dr Magali Taiel, Vice-President of Clinical Development at GenSight, will give an oral presentation.

  • Title: GS010, a Novel Gene Therapy for Leber Hereditary Optic Neuropathy
  • Session & Time: Session III, 3:23-3:28pm PDT